In univariable analysis, low EZH1 protein expression was associated with poor prognosis (T-NHL: median OS 16.0 vs. 124.0 months; p = 0.016; nodal T-NHL: median OS 16.0 vs. 124.0 months; p = 0.020). Here, EZH1 is linked to non-Hodgkin lymphoma.